4ab56d38-cef9-4fbc-8b60-3cadbe254495.pdf

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

GLOBAL BIO-CHEM TECHNOLOGY GROUP COMPANY LIMITED

大 成 生 化 科 技 集 團 有 限 公 司 *

(incorporated in the Cayman Islands with limited liability)

(Stock Code: 00809)
  1. VOTING RESULTS OF RESOLUTIONS PROPOSED AT ANNUAL GENERAL MEETING
  2. RETIREMENT OF DIRECTOR AND
  3. CHANGE OF COMPOSITION OF CORPORATE GOVERNANCE COMMITTEE

The Board is pleased to announce that all ordinary resolutions proposed at the Annual General Meeting were duly passed by way of poll.

Ms. Liu Fang has ceased to be an executive Director, member of the Corporate Governance Committee and the Chief Financial Officer upon her retirement by rotation from the Board at the Annual General Meeting.

Following the cessation of Ms. Liu Fang as a member of the Corporate Governance Committee, Mr. Li Shuguang, an executive Director, has been appointed as a member of the Corporate Governance Committee.

Reference is made to the circular ("Circular") of Global Bio-chem Technology Group Company Limited ("Company") dated 29 April 2016. Terms used herein shall have the same meanings as defined in the Circular unless the context requires otherwise.

* for identification purposes only

VOTING RESULTS OF THE ANNUAL GENERAL MEETING

Pursuant to Rule 13.39(5) of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited, the board ("Board") of directors of the Company is pleased to announce that the following ordinary resolutions ("Resolutions") were duly passed by the shareholders of the Company ("Shareholders") by way of poll at the annual general meeting of the Company ("Annual General Meeting") held on 6 June 2016:

Resolutions

Number of votes (%)

FOR

AGAINST

1.

To receive and approve the audited consolidated financial statements and the reports of the directors and the auditors of the Company for the year ended 31 December 2015

3,352,488,065 shares

(98.34%)

56,762,359 shares

(1.66%)

2.

(a)

as a separate resolution, to re-elect Mr. Ng Kwok Pong as independent non-executive director of the Company

3,409,250,424 shares

(100.00%)

0 share

(0.00%)

(b)

as a separate resolution, to re-elect Mr. Yeung Kit Lam as independent non-executive director of the Company

3,409,250,424 shares

(100.00%)

0 share

(0.00%)

(c) as a separate resolution, to re-elect Ms. Chiu Lai Ling Shirley as independent non-executive director of the Company

3,409,250,424 shares

(100.00%)

0 share

(0.00%)

(d)

as a separate resolution, to authorise the board of directors to fix the directors' remuneration

3,409,250,424 shares

(100.00%)

0 share

(0.00%)

3.

To re-appoint the auditors and authorise the board of directors to fix their remuneration

3,409,250,424 shares

(100.00%)

0 share

(0.00%)

4.

To grant a general mandate to the directors to allot, issue or otherwise deal with Company's shares

3,397,420,464 shares

(99.65%)

11,829,960 shares

(0.35%)

5.

To grant a general mandate to the directors to purchase the Company's shares

3,409,254,424 shares

(100.00%)

0 share

(0.00%)

6.

To add the number of shares repurchased by the Company to the mandate granted to the directors under resolution no. 4

3,397,440,464 shares

(99.65%)

11,809,960 shares

(0.35%)

As at the date of the Annual General Meeting, the total issued share capital of the Company was HK$639,899,836 divided into 6,398,998,360 ordinary shares of HK$0.10 each ("Shares") in the capital of the Company which was the total number of Shares entitling the Shareholders to attend

and vote on any of the Resolutions at the Annual General Meeting. There was no Shares entitling the Shareholders to attend and abstain from voting in favour of any of the Resolutions at the Annual General Meeting. No Shareholder was required under the Listing Rules to abstain from voting on any of the Resolutions at the Annual General Meeting.

The Company's branch share registrar, Tricor Tengis Limited, was appointed as the scrutineer at the Annual General Meeting for the vote-taking.

RETIREMENT OF DIRECTOR

Ms. Liu Fang has ceased to be an executive Director, member of the corporate governance committee of the Company ("Corporate Governance Committee") and the chief financial officer of the Company ("Chief Financial Officer") upon her retirement by rotation from the Board at the Annual General Meeting due to her wish to focus on other career opportunities. Ms. Liu has confirmed that she has no disagreement with the Board and there is no matter relating to her retirement that needs to be brought to the attention of the Shareholders.

The Board would like to express its gratitude to Ms. Liu for her contribution to the Company during the tenure of her office.

CHANGE OF COMPOSITION OF CORPORATE GOVERNANCE COMMITTEE

The Board further announces that following the cessation of Ms. Liu Fang as a member of the Corporate Governance Committee, with effect from 6 June 2016, Mr. Li Shuguang has been appointed as a member of the Corporate Governance Committee.

An updated list of Directors and their roles and function including the composition of each of the committees of the Board will be made available on the websites of the Stock Exchange and the Company in due course.

Yours faithfully,

For and on behalf of the Board

Global Bio-chem Technology Group Company Limited Wang Qiu

Chairman

Hong Kong, 6 June 2016

As at the date of this announcement, the board of directors comprises three executive directors, namely Ms. Wang Qiu, Mr. Wang Jian and Mr. Li Shuguang; two non-executive directors, namely Mr. Qiu Zhuang and Mr. Xing Lizhu; and three independent non-executive directors, namely Mr. Ng Kwok Pong, Mr. Yeung Kit Lam and Ms. Chiu Lai Ling Shirley.

Global Bio-Chem Technology Group Co. Ltd. published this content on 06 June 2016 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 06 June 2016 10:54:06 UTC.

Original documenthttp://www.globalbiochem.com/attachment/2016060618470100002533906_en.pdf

Public permalinkhttp://www.publicnow.com/view/0A5A0D78C889D8C22AA46517BF55D2B75D5DB800